Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation
- PMID:15913581
- DOI: 10.1016/j.cardiores.2005.04.016
Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation
Abstract
Background: Atrial fibrillation (AF) is associated with extracellular matrix remodeling involving atrial fibrosis and atrial dilatation. Angiotensin II mediated pathways and matrix metalloproteinases (MMPs) have been implicated in these processes. Our aim was to study atrial structural remodeling and the expression of the angiotensin receptor subtypes and MMPs and their inhibitors (TIMPs) in patients with mitral valve disease with and without AF.
Methods and results: Biopsies from right and left atrial appendages (RA and LA) were taken from patients undergoing CABG (n=9, all in sinus rhythm (SR)) or mitral valve surgery (MVS; n=19; 9 with permanent AF and 10 in SR). Patients with MVS and AF had significantly larger atria (versus MVS and SR: p=0.02; versus CABG: p<0.01). The MVS patients had significantly more fibrosis than the control CABG group. Fibrosis was increased in both the AF and SR MVS groups in the LA, but only in the MVS-AF group in the RA. These AF patients had significantly more tricuspid regurgitation than SR patients. MMP-1 was down-regulated in LA of MVS patients (p=0.02) independent of the underlying rhythm (SR or AF; p=0.95). In RA biopsies, MMP-1 was down-regulated only in the MVS and AF group. MMP-9 was down-regulated in the MVS patients compared to CABG both in the RA and LA, and without a difference between the SR and AF groups. Protein expression of AT-1, AT-2, MMP-2, TIMP-1, -2 and -4, TNF-alpha, and TNF-alpha-converting enzyme did not differ significantly between the 3 groups.
Conclusions: Concordant changes between MMP-expression and fibrosis during mitral valve disease, both in LA and RA, suggest involvement of MMPs in structural atrial remodeling. AF itself did not contribute to altered fibrosis or MMP-expression in the LA. The association between AF and RA changes may be precipitated by greater hemodynamic load due to tricuspid regurgitation in these patients.
Similar articles
- Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases.Qian Y, Meng J, Tang H, Yang G, Deng Y, Wei D, Xiang B, Xiao X.Qian Y, et al.Europace. 2010 Mar;12(3):371-7. doi: 10.1093/europace/eup438. Epub 2010 Jan 26.Europace. 2010.PMID:20106797
- Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, Ishida M, Shingu T, Sueda T, Yoshizumi M, Chayama K.Nakano Y, et al.J Am Coll Cardiol. 2004 Mar 3;43(5):818-25. doi: 10.1016/j.jacc.2003.08.060.J Am Coll Cardiol. 2004.PMID:14998623
- [Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation].Wang W, Wu PS, Yang XL.Wang W, et al.Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):1160-2.Nan Fang Yi Ke Da Xue Xue Bao. 2010.PMID:20501421Chinese.
- TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.Vanhoutte D, Heymans S.Vanhoutte D, et al.J Mol Cell Cardiol. 2010 Mar;48(3):445-53. doi: 10.1016/j.yjmcc.2009.09.013. Epub 2009 Sep 30.J Mol Cell Cardiol. 2010.PMID:19799912Review.
- [Biology of the substrate of atrial fibrillation].Hatem S.Hatem S.Biol Aujourdhui. 2012;206(1):5-9. doi: 10.1051/jbio/2012004. Epub 2012 Apr 3.Biol Aujourdhui. 2012.PMID:22463991Review.French.
Cited by
- Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation.Turagam MK, Mirza M, Werner PH, Sra J, Kress DC, Tajik AJ, Jahangir A.Turagam MK, et al.Cardiol Rev. 2016 Mar-Apr;24(2):76-87. doi: 10.1097/CRD.0000000000000059.Cardiol Rev. 2016.PMID:25699982Free PMC article.Review.
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner DR, Nattel S.Goette A, et al.Heart Rhythm. 2017 Jan;14(1):e3-e40. doi: 10.1016/j.hrthm.2016.05.028. Epub 2016 Jun 10.Heart Rhythm. 2017.PMID:27320515Free PMC article.Review.No abstract available.
- Prognostic value of left atrial reservoir function in patients with severe primary mitral regurgitation undergoing mitral valve repair.Stassen J, van Wijngaarden AL, Butcher SC, Palmen M, Herbots L, Bax JJ, Delgado V, Ajmone Marsan N.Stassen J, et al.Eur Heart J Cardiovasc Imaging. 2022 Dec 19;24(1):142-151. doi: 10.1093/ehjci/jeac058.Eur Heart J Cardiovasc Imaging. 2022.PMID:35301525Free PMC article.
- Prognostic value of left atrial strain in patients with moderate asymptomatic mitral regurgitation.Cameli M, Pastore MC, Righini FM, Mandoli GE, D'Ascenzi F, Lisi M, Nistor D, Sparla S, Curci V, Di Tommaso C, Marino F, Stricagnoli M, Mondillo S.Cameli M, et al.Int J Cardiovasc Imaging. 2019 Sep;35(9):1597-1604. doi: 10.1007/s10554-019-01598-6. Epub 2019 Apr 10.Int J Cardiovasc Imaging. 2019.PMID:30972528
- MicroRNAs and atrial fibrillation: mechanisms and translational potential.Luo X, Yang B, Nattel S.Luo X, et al.Nat Rev Cardiol. 2015 Feb;12(2):80-90. doi: 10.1038/nrcardio.2014.178. Epub 2014 Nov 25.Nat Rev Cardiol. 2015.PMID:25421165Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous